BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17076597)

  • 1. Delivery systems and adjuvants for oral vaccines.
    Lavelle EC; O'Hagan DT
    Expert Opin Drug Deliv; 2006 Nov; 3(6):747-62. PubMed ID: 17076597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunisation: adjuvants and delivery systems.
    Moyle PM; McGeary RP; Blanchfield JT; Toth I
    Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines.
    Criscuolo E; Caputo V; Diotti RA; Sautto GA; Kirchenbaum GA; Clementi N
    J Immunol Res; 2019; 2019():8303648. PubMed ID: 30949518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioadhesive delivery systems for mucosal vaccine delivery.
    Baudner BC; O'Hagan DT
    J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunisation: Successful approaches to targeting different tissues.
    Ferro VA; Carter KC
    Methods; 2006 Feb; 38(2):61-4. PubMed ID: 16442812
    [No Abstract]   [Full Text] [Related]  

  • 9. Current state and challenges in developing oral vaccines.
    Vela Ramirez JE; Sharpe LA; Peppas NA
    Adv Drug Deliv Rev; 2017 May; 114():116-131. PubMed ID: 28438674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
    Mann JF; Acevedo R; Campo JD; PĂ©rez O; Ferro VA
    Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in vaccine adjuvants.
    Singh M; O'Hagan DT
    Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing efficacy of mucosal vaccines.
    Gebril A; Alsaadi M; Acevedo R; Mullen AB; Ferro VA
    Expert Rev Vaccines; 2012 Sep; 11(9):1139-55. PubMed ID: 23151169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
    Marasini N; Kaminskas LM
    Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel vaccine development strategies for inducing mucosal immunity.
    Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
    Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The path to a successful vaccine adjuvant--'the long and winding road'.
    O'Hagan DT; De Gregorio E
    Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal vaccine innovation.
    Jabbal-Gill I
    J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in oral vaccines and mucosal adjuvants.
    Subiza JL; El-Qutob D; Fernandez-Caldas E
    Recent Pat Inflamm Allergy Drug Discov; 2015; 9(1):4-15. PubMed ID: 25669205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.